Minerva Surgical, Inc. Common Stock
UTRS
UTRS was delisted on the 28th of December, 2023.
13 hedge funds and large institutions have $6.04M invested in Minerva Surgical, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less funds holding
Funds holding: 17 → 13 (-4)
36% less capital invested
Capital invested by funds: $9.43M → $6.04M (-$3.39M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$18K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$6.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VVM
Versant Venture Management
San Francisco,
California
|
-$362K |
| 2 |
Millennium Management
New York
|
-$14.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.51K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$6.45K |
UTRS Hedge Fund Activity: Q3 2023 in Review
13 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Minerva Surgical, Inc. Common Stock (UTRS) for Q3 2023, worth a combined $6.04M — down 36% from $9.43M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of UTRS and 1 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 1 added.
The largest buyer was Geode Capital Management, adding an estimated $18K. The largest seller was Versant Venture Management, cutting an estimated $362K.
- 13 institutional investors held Minerva Surgical, Inc. Common Stock (UTRS) as of Q3 2023, down from 17 in Q2 2023.
- Funds reported $6.04M of Minerva Surgical, Inc. Common Stock stock for Q3 2023, down 36% quarter-over-quarter.
- 1 fund opened new Minerva Surgical, Inc. Common Stock positions in Q3 2023 and 5 closed out, a net change of -4 holders.
- The largest Minerva Surgical, Inc. Common Stock buyer in Q3 2023 was Geode Capital Management, an estimated $18K added.
- The largest Minerva Surgical, Inc. Common Stock seller in Q3 2023 was Versant Venture Management, an estimated $362K sold.
Based on aggregated 13F filings for Q3 2023.